Laboratorios Sanfer
PrivateLast Round
Growth Equity
Aug 19, 2019
Est. Valuation
$2.08B
Total Funding Raised
$500M
Company Overview
Laboratorios Sanfer is a pharmaceutical company that manufactures and supplies a range of products including prescription drugs, generic and brand generic drugs, oncological and OTC drugs, as well as veterinary products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laboratorios Sanfer Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Laboratorios Sanfer Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Aug 19, 2019 |
Laboratorios Sanfer Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Caisse de dépôt et placement du Québec | Growth Equity |
| General Atlantic | Growth Equity |
Laboratorios Sanfer Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Laboratorios Sanfer's valuation, stock price, and market status.